Paul R. Thompson

Paul R. Thompson

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School

Affiliated withUniversity of Massachusetts Medical School

Research Area

Biography

Paul R. Thompson has not added Biography.
If you are Paul R. Thompson and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Publication title

Cited by 168

2015

Other Publications

Article
Year
Mechanism of aminoglycoside antibiotic kinase APH(3')-IIIa: role of the nucleotide positioning loop.

Biochemistry| PubMed ID: 12033933

2002
2003
2004
Regulation of the p300 HAT domain via a novel activation loop.

Nature structural & molecular biology| PubMed ID: 15004546

2004
2004
2005
2006
2006
2006
2006
Methyllysine analogs: rewriting the code.

Nature chemical biology| PubMed ID: 17438548

2007
2007
A selective chemical probe for coenzyme A-requiring enzymes.

Angewandte Chemie (International ed. in English)| PubMed ID: 17768748

2007
Peptide borono lectins (PBLs): a new tool for glycomics and cancer diagnostics.

Chembiochem : a European journal of chemical biology| PubMed ID: 17924602

2007
2007
2008
2008
In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.

Journal of the American Chemical Society| PubMed ID: 18338885

2008
2008
Regulation of p53 target gene expression by peptidylarginine deiminase 4.

Molecular and cellular biology| PubMed ID: 18505818

2008
2008
The protein acetyltransferase ARD1: a novel cancer drug target?

Current cancer drug targets| PubMed ID: 18991565

2008
2009
2008
Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.

Current opinion in drug discovery & development| PubMed ID: 19736621

2009
2010
2010
2010
2010
2011
Protein arginine deiminase 4: a target for an epigenetic cancer therapy.

Cellular and molecular life sciences : CMLS| PubMed ID: 20706768

2011
A fluopol-ABPP HTS assay to identify PAD inhibitors.

Chemical communications (Cambridge, England)| PubMed ID: 20740228

2010
2010
2011
2011
2011
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.

American journal of physiology. Gastrointestinal and liver physiology| PubMed ID: 21415415

2011
2011
2011
2011
2011
Kinase consensus sequences: a breeding ground for crosstalk.

ACS chemical biology| PubMed ID: 21721511

2011
2011
2011
2012
2012
Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).

The Journal of biological chemistry| PubMed ID: 22219200

2012
2012
2012
2012
2012
Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 22853951

2012
2012
2012
2012
2013
Activation of PAD4 in NET formation.

Frontiers in immunology| PubMed ID: 23264775

2012
2013
2012
2013
2014
2013
2013
2013
2013
2014
2014
2014
2014
2014
2014
Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 24671707

2014
Pluripotency: citrullination unravels stem cells.

Nature chemical biology| PubMed ID: 24743255

2014
2014
2014
A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programming.

BioEssays : news and reviews in molecular, cellular and developmental biology| PubMed ID: 24889365

2014
2014
2014
2014
2015
2015
2015
Inhibiting protein arginine deiminases has antioxidant consequences.

The Journal of pharmacology and experimental therapeutics| PubMed ID: 25635139

2015
2015
2015